Socomed Pharma Private Limited vs Biotime Pharmaceuticals Private Limited — COMIP/132/2026

Case under Copyright Act Section section17(c)45. Disposed: Contested--DISPOSED OFF on 15th June 2026.

Case disposed

CNR: HCBM020038932025

e-Filing Number

04-02-2025

Filing Number

COMIP/3893/2025

Filing Date

05-Feb-2025

Registration No

COMIP/132/2026

Registration Date

26-Mar-2026

Judge

Hon'ble Shri Justice Madhav J. Jamdar

Coram

Hon'ble Shri Justice Madhav J. Jamdar

Bench Type

Single

Category

MERCANTILE LAWS COMMERCIAL TRANSACTIONS , BANKS ( 28 )

Sub-Category

COPY RIGHTS ( 6 )

Judicial Branch

Original

Decision Date

15-Jun-2026

Nature of Disposal

Contested--DISPOSED OFF

Last updated 19-Jun-2026

Acts & Sections

Copyright Act Section section17(c)45
Trade Marks Rules 2002 Section section56.62

Petitioner(s)

  1. 1.Socomed Pharma Private Limited

    Adv. SHEKHAR BHAGAT

Respondent(s)

  1. 1.Biotime Pharmaceuticals Private Limited

Case History

  1. Case disposedDisposed

  2. 06-Jul-2026

    Due Matters - Adjourned OS

    Hon'ble Justice Sharmila U. Deshmukh

  3. 15-Jun-2026

    Hon'ble Shri Justice Madhav J. JamdarView PDF

    Case Summary: COMIP/132/2026 Socomed Pharma Private Limited v. Biotime Pharmaceuticals Private Limited & Others The Bombay High Court disposed of this intellectual property suit through a settlement agreement (Consent Terms) signed by all parties on June 15, 2026. Socomed Pharma alleged copyright and trademark infringement of its "COLDITABZ" pharmaceutical product by the defendants through use of confusingly similar packaging and marks. The defendants acknowledged Socomed's ownership of the registered trademark "COLDITABZ" (Class 5, Registration No. 1847751) and copyrights in the artistic work, and agreed to: (a) cease all infringing use of the mark and packaging; (b) destroy existing counterfeit inventory; (c) provide sales and export documentation; and (d) pay damages of ₹5,00,000 to Socomed. The court accepted these undertakings and disposed of the suit accordingly. This case analysis is maintained by casestatus.in based on publicly available court records.

  4. 05-May-2026

    Hon'ble Justice Sharmila U. DeshmukhView PDF

  5. 05-May-2026

    Due Matters - Adjourned OS

    Hon'ble Justice Sharmila U. Deshmukh

  6. 11-Mar-2026

    Hon'ble Justice Sharmila U. DeshmukhView PDF

  7. 11-Mar-2026

    Due Matters - Adjourned OS

    Hon'ble Justice Sharmila U. Deshmukh

  8. 04-Feb-2026

    Hon'ble Justice Sharmila U. DeshmukhView PDF

  9. 04-Feb-2026

    Due Matters - Adjourned OS

    Hon'ble Justice Sharmila U. Deshmukh

  10. 07-Jan-2026

    Hon'ble Justice Sharmila U. DeshmukhView PDF

  11. 07-Jan-2026

    Due Matters - Adjourned OS

    Hon'ble Justice Sharmila U. Deshmukh

  12. 01-Dec-2025

    Due Matters - Adjourned OS

    Hon'ble Justice Sharmila U. Deshmukh

  13. 13-Nov-2025

    Due Matters - Adjourned OS

    Hon'ble Justice Shri Arif S. Doctor

  14. 24-Sep-2025

    Hon'ble Justice Shri Arif S. DoctorView PDF

  15. 08-Sep-2025

    Due Matters - Adjourned OS

    Hon'ble Justice Sharmila U. Deshmukh

  16. 07-Aug-2025

    Hon'ble Justice Sharmila U. DeshmukhView PDF

  17. 07-Aug-2025

    Due Matters - Adjourned OS

    Hon'ble Justice Sharmila U. Deshmukh

  18. 13-Jun-2025

    Balance Board

    Hon'ble Shri Justice Manish Pitale

  19. 16-Apr-2025

    Hon'ble Shri Justice Manish PitaleView PDF

  20. 16-Apr-2025

    First hearing

    Initial hearing scheduled

  21. 19-Mar-2025

    Hon'ble Shri Justice Manish PitaleView PDF

  22. 05-Feb-2025

    Case filed

    Registration No. COMIP/132/2026

casestatus.in Summary

Case Summary: COMIP/132/2026 Socomed Pharma Private Limited v. Biotime Pharmaceuticals Private Limited & Others The Bombay High Court disposed of this intellectual property suit through a settlement agreement (Consent Terms) signed by all parties on June 15, 2026. Socomed Pharma alleged copyright and trademark infringement of its "COLDITABZ" pharmaceutical product by the defendants through use of confusingly similar packaging and marks. The defendants acknowledged Socomed's ownership of the registered trademark "COLDITABZ" (Class 5, Registration No. 1847751) and copyrights in the artistic work, and agreed to: (a) cease all infringing use of the mark and packaging; (b) destroy existing counterfeit inventory; (c) provide sales and export documentation; and (d) pay damages of ₹5,00,000 to Socomed. The court accepted these undertakings and disposed of the suit accordingly. This case analysis is maintained by casestatus.in based on publicly available court records.

Explore other courts

District Courts Supreme Court
Search Another Case